The EIB funds come as part of an InvestEU programme, which aims to disperse €372bn ($442.2bn) in investment grants between 2021 and 2027.

VANCOUVER, British Columbia--(BUSINESS WIRE)--To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop ...

A research team at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan report they have created a model of the blood-brain barrier using modularized tissue derived from human cells. The ...

UCLA scientists have developed advanced miniature 3D tumor organoid models that make it possible to study glioblastoma tumors in a setting that closely mirrors the human brain, shedding light on how ...

BlueOcean Global Corp., a medical device company focused on limb preservation and complex reconstruction, today announced U.S ...

Spectral AI's DeepView System excels over physicians in identifying non-healing burn tissue, aiming for FDA clearance by mid-2025. Spectral AI has announced positive results from its Burn Validation ...

BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue ...

The university's scientists have received a $28.5 million award from the Advanced Research Projects Agency for Health to develop a transplantable 3D-printed liver patch. The initiative ...

New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched ...